Kangmei Pharmaceutical Co.,Ltd. Posted 49.8 Million Yuan Net Loss in First Quarter of 2023

Kangmei Pharmaceutical Co.,Ltd. (康美药业股份有限公司) (600518.SH) reported a net loss of 49.8 million yuan in the first quarter of 2023, narrowing 55.4% year-on-year.

Meanwhile, the company posted 1.1 billion yuan in revenue, up 22.5% year-on-year.

At the end of the reporting period, it had 14.8 billion yuan in total assets and 7.9 billion yuan in total liabilities, with a liability-to-asset ratio of 53.2%.